Drug makers try to bring back Cox-2 inhibitors
Article Abstract:
Although Merck & Company Inc. discontinued the painkiller Vioxx two years ago amid reports of increased cardiovascular problems, pharmaceutical companies are now reintroducing this class of drugs, COX-2 inhibitors. Novartis AG will introduce Prexige in Europe, and Merck is seeking FDA approval for Arcoxia, while Pfizer Inc. is reintroducing Celebrex.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Roche's pick for next CEO marks a bet on diagnostics: Schwan to push technology that spots, tracks disease; first-half net grew 24%
Article Abstract:
Swiss pharmaceutical firm Roche Holding Ltd. named Severin Schwan as its next chief executive officer, emphasizing the company's interest on tools and machines that monitor and diagnose disease. Net income rose 24% to reach $4.09 bil in the first half of 2007, with sales rising by 15%.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Promotional muscle: how Glaxo marketed an ailment; an ad blitz turned Requip into a big seller to treat restless-legs syndrome
Article Abstract:
GlaxoSmithKline PLC's introduction of Requip, a medication to treat restless legs syndrome, has led to sales of over $500 million this year. Requ ip's success can be attributed to an aggressive marketing campaign by the company, which included publicizing the disorder to physicians.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Akzo Nobel brings in Henkel to win a deal for ICI: move marks new effort to jointly buy a rival, then later break it up
- Abstracts: Peugeot weighs joint venture to build vehicles for China. Tata may bid for Ford's luxury brands: Indian firm's purchase of Jaguar, Land Rover would widen reach
- Abstracts: Decision-maker's preferences modeling in the stochastic goal programming
- Abstracts: Identifying intraorganisational and interorganisational alliance conflictsua longitudinal study of an alliance pilot project in the high technology industry
- Abstracts: An unusual race to become Glaxo's next CEO. Morgan Stanley to-do list: Get boss, strategy. Liz Claiborne names pharmaceutical executive as CEO